4.3 Article

The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients

期刊

ONCOTARGET
卷 6, 期 2, 页码 755-770

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.2712

关键词

Fibrolamellar; hepatocellular carcinoma; cancer; genome; sequencing

资金

  1. Fibrolamellar Cancer Foundation
  2. Rockefeller University Center for Clinical and Translational Science [2UL1RR024143]
  3. National Institutes of Health/National Cancer Institute [5P30CA008748]

向作者/读者索取更多资源

Fibrolamellar hepatocellular carcinoma is a rare, malignant liver tumor that often arises in the otherwise normal liver of adolescents and young adults. Previous studies have focused on biomarkers and comparisons to traditional hepatocellular carcinoma, and have yielded little data on the underlying pathophysiology. We performed whole genome sequencing on paired tumor and normal samples from 10 patients to identify recurrent mutations and structural variations that could predispose to oncogenesis. There are relatively few coding, somatic mutations in this cancer, putting it on the low end of the mutational spectrum. Aside from a previously described heterozygous deletion on chromosome 19 that encodes for a functional, chimeric protein, there were no other recurrent structural variations that contribute to the tumor genotype. The lack of a second-hit mutation in the genomic landscape of fibrolamellar hepatocellular carcinoma makes the DNAJB1-PRKACA fusion protein the best target for diagnostic and therapeutic advancements. The mutations, altered pathways and structural variants that characterized fibrolamellar hepatocellular carcinoma were distinct from those in hepatocellular carcinoma, further defining it as a distinct carcinoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据